Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001144204-19-035234

Options or other derivatives

  • Chief Medical Officer acquired 160,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

GRAF FINCKENSTEIN FRIEDRICH · Chief Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-07-18 Grant or award : show line 1 in the form Stock Option (right to buy) +160,000 $25.78 2029-07-17 160,000 160,000 D
Loading xslF345X03/tv525514_4.xml…